At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 116 enrolled
Drug / intervention
Platelet Rich Plasmabiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Role of Platelet Rich Plasma in Supporting the Recovery of Post-partum Levator Ani Muscle Trauma
In Brief
A Phase 3 clinical trial evaluating Platelet Rich Plasma for Pelvic Floor Disorders. Completed, enrolled 116 participants across 1 site.
Detailed Summary
Levator trauma (ballooning) often occurs after vaginal delivery. Platelet rich plasma injection after delivery showed reduced hiatal area and maintain levator muscle strength.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPelvic Floor Disorders
CountriesIndonesia
CollaboratorsIndonesia University
Timeline
Phase 3CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartNov 2016
First PostedJan 2017
Primary CompletionJan 2019
Study CompletionJan 2020
TodayJul 2026
First PostedJan 16, 2017
Enrollment StartNov 1, 2016
Primary CompletionJan 1, 2019
Study CompletionJan 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 9.5 years ago
Interventions
Platelet Rich Plasmabiological
Platelet rich plasma is an autologous blood with high amount of platelet. It produced by obtaining patient's whole blood and processed by centrifugation and activation by CaCl2.